ARMISTICE CAPITAL LLC 13D and 13G filings for CNS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:25 pm Purchase | 2023-12-31 | 13G | CNS Pharmaceuticals, Inc. CNSP | ARMISTICE CAPITAL LLC | 270 9.990% | 204 (+308.69%) | Filing |
| 2023-02-14 12:23 pm Purchase | 2022-12-31 | 13G | CNS Pharmaceuticals, Inc. CNSP | ARMISTICE CAPITAL LLC | 66 9.990% | 66 (New Position) | Filing |